Logistics and Waste Management Benefits of depo-subQ in Uniject

To understand how the current intramuscular version of depot medroxyprogesterone acetate (DMPA) injectable contraceptive compares with the new formulation packages in the Uniject, PATH conducted a comparative analysis of the two products. The analysis focused on the waste management implications, identifying key quantitative and qualitative differences between the two products.

Year: 
2011
Organization: 
PATH
Languages: 
English